Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

2 Tampilan
administrator
administrator
07/10/23

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

  • Kategori

Menampilkan lebih banyak

0 Komentar Sortir dengan

Tidak ada komentar yang ditemukan

Komentar Facebook

Berikutnya